During April 2021, the number of common shares increased by 5,000,000 as a result of the completed directed new share issue. The number of C-shares also increased in April by 397,641 following a directed share issue and repurchase of these shares (the C-shares are held by Ascelia Pharma). The issue of C-shares is linked to the company's share saving program (LTI 2020), which was resolved by the Annual General Meeting on May 6, 2020.
As of April 30, 2021, the number of shares amounts to 34,576,448, of which 33,668,262 are common shares with one vote per share and 908,186 are C-shares with one tenth of a vote each. The total number of votes in the company amounts to 33,759,080.6.